| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/26/2001 | EP1136570A2 Carrier for gene detection and it's use for detecting validity of interferon therapy |
| 09/26/2001 | EP1136567A1 Method and kit for the screening, the detection and /or the quantification of transcriptional factors |
| 09/26/2001 | EP1136564A2 Reagent for glutamic-pyruvic transaminase assay |
| 09/26/2001 | EP1136563A2 Method of staining, and detecting and counting bacteria |
| 09/26/2001 | EP1136556A1 Multivalent antigen-binding proteins |
| 09/26/2001 | EP1136548A1 Novel trypsin family serine proteases |
| 09/26/2001 | EP1136547A2 Adamts polypeptides, nucleic acids encoding them, and uses thereof |
| 09/26/2001 | EP1136504A1 Receptor for Latrotoxin from insects |
| 09/26/2001 | EP1136502A1 Insect ligand-gated anion channels |
| 09/26/2001 | EP1136501A2 Receptors for peptides from insect origin |
| 09/26/2001 | EP1136500A2 Seroreactive regions from the HPV proteins E1 and E2 |
| 09/26/2001 | EP1136447A1 Water purifying apparatus and method for purifying water |
| 09/26/2001 | EP1136141A1 Treating apparatus, treating method and method of treating soil |
| 09/26/2001 | EP1135689A1 Stabilisation of calibrators containing cytokeratin |
| 09/26/2001 | EP1135688A2 Methods and compositions useful for targeting activated vitronectin receptor alpha(nu)-beta(3) |
| 09/26/2001 | EP1135687A1 An immunoassay for the determination of transmissible spongiform encephalopathies in mammals |
| 09/26/2001 | EP1135686A1 Diagnosis of stage or aggressiveness of cancer |
| 09/26/2001 | EP1135685A2 Methods for quantitation of hla-dr and cd11b |
| 09/26/2001 | EP1135684A1 IMPROVED SPECIFICITY IN THE DETECTION OF ANTI-RUBELLA IgM ANTIBODIES |
| 09/26/2001 | EP1135683A2 New assay |
| 09/26/2001 | EP1135682A1 Nanoparticles with polymer shells |
| 09/26/2001 | EP1135681A1 Three-hybrid screening method for ligand-protein interactions |
| 09/26/2001 | EP1135680A1 A high-throughput system for evaluating the clinical utility of molecular targets in tissue samples |
| 09/26/2001 | EP1135679A1 Multichemistry measuring device and test strips |
| 09/26/2001 | EP1135678A2 Analyte test instrument having improved calibration and communications processes |
| 09/26/2001 | EP1135677A1 In vivo biosensor apparatus and method of use |
| 09/26/2001 | EP1135673A1 Histological processing of tissue and other material |
| 09/26/2001 | EP1135535A2 Development of anti-microbial agents based on bacteriophage genomics |
| 09/26/2001 | EP1135533A1 Method and system for detecting oligonucleotides in a sample |
| 09/26/2001 | EP1135531A1 Methods for introducing heterologous cells into fish |
| 09/26/2001 | EP1135530A2 Multiplex amplification of short tandem repeat loci |
| 09/26/2001 | EP1135528A2 Length determination of nucleic acid repeat sequences by discontinuous primer extension |
| 09/26/2001 | EP1135527A2 Cloning and copying on surfaces |
| 09/26/2001 | EP1135526A2 Method for identifying cytosine methylation patterns in genomic dna |
| 09/26/2001 | EP1135524A1 Array and method for analysing nucleic acid sequences |
| 09/26/2001 | EP1135521A2 Method of screening candidate compounds for susceptibility to oxidative metabolism |
| 09/26/2001 | EP1135519A1 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases |
| 09/26/2001 | EP1135509A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/26/2001 | EP1135507A1 Fruit flavour related genes and use thereof |
| 09/26/2001 | EP1135503A2 DRUG TARGETS IN $i(CANDIDA ALBICANS) |
| 09/26/2001 | EP1135501A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/26/2001 | EP1135500A1 Control of flowering |
| 09/26/2001 | EP1135498A1 Antibody variants with higher binding affinity compared to parent antibodies |
| 09/26/2001 | EP1135496A2 Ucp5 |
| 09/26/2001 | EP1135495A2 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
| 09/26/2001 | EP1135494A2 Neuron-associated proteins |
| 09/26/2001 | EP1135491A2 Methods and compositions for inhibiting neoplastic cell growth |
| 09/26/2001 | EP1135490A1 Human vanilloid receptors and their uses |
| 09/26/2001 | EP1135489A1 Pth1r and pth3r receptors |
| 09/26/2001 | EP1135488A1 Human semaphorin 6a-1 (sema6a-1), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target |
| 09/26/2001 | EP1135486A1 RECOMBINANT SOLUBLE Fc RECEPTORS |
| 09/26/2001 | EP1135485A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/26/2001 | EP1135484A2 Gtpase associated proteins |
| 09/26/2001 | EP1135483A2 Cytokine signal regulators |
| 09/26/2001 | EP1135477A1 Humanized monoclonal antibodies |
| 09/26/2001 | EP1135467A1 Psca: prostate stem cell antigen and uses thereof |
| 09/26/2001 | EP1135463A2 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| 09/26/2001 | EP1135414A2 Allo and auto-reactive t-cell epitopes |
| 09/26/2001 | EP1135413A2 Proteins that bind angiogenesis-inhibiting proteins, compoisitions and methods of use thereof |
| 09/26/2001 | EP1135412A2 Tumor necrosis factor receptor homologue-1 (trh1) |
| 09/26/2001 | EP1135408A1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands |
| 09/26/2001 | EP1135336A1 Materials for solid-state gas sensors |
| 09/26/2001 | EP1135169A1 Pharmaceutical composition comprising an anti-cancer agent and at least a peptide |
| 09/26/2001 | EP1135166A1 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 09/26/2001 | EP1135160A2 Boron neutron capture therapy using pre-targeting methods |
| 09/26/2001 | EP1135149A1 Pgc-1, a novel brown fat ppar gamma coactivator |
| 09/26/2001 | EP1135144A1 Compositions and methods for regulating bacterial pathogenesis |
| 09/26/2001 | EP1135132A2 Inhibitors of multidrug transporters |
| 09/26/2001 | EP1135052A1 Devices and methods for frequent measurement of an analyte present in a biological system |
| 09/26/2001 | EP1135031A1 Method for testing a fodder component for the feeding of ruminants |
| 09/26/2001 | EP0956509B1 Use of crotalus viridis helleri venom, method and kit for determining the reactivity of activated protein c |
| 09/26/2001 | EP0932664B1 A cell-free system for initiation of dna replication |
| 09/26/2001 | EP0920537A4 Method for chromosomes classification |
| 09/26/2001 | EP0859792B1 Tryptase polyclonal antibody and purification method for use in human tryptase immunoassay |
| 09/26/2001 | EP0834145B1 A method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions |
| 09/26/2001 | EP0809653B1 Helicobacter pylori antigen |
| 09/26/2001 | EP0771325B1 Process for modifying the stability of antibodies |
| 09/26/2001 | EP0733205B1 Method for removal of binding proteins from ligands |
| 09/26/2001 | EP0709680B1 Magnetic particles covered with gelatin and immunoassay using the same |
| 09/26/2001 | EP0702558B1 Novel opioid peptide inhibitors |
| 09/26/2001 | EP0672191B1 Quantitative detection of macromolecules with fluorescent oligonucleotides |
| 09/26/2001 | EP0641227B1 Piercing and sampling probe |
| 09/26/2001 | EP0584321B1 Process and device for detecting impurities in a textile test sample |
| 09/26/2001 | EP0528991B1 Detectably labelled marker component comprising a fluorophore moiety , fluorescent probe comprising the marker component and uses thereof. |
| 09/26/2001 | EP0495910B1 Production and use of human nm23-h2 protein and antibodies therefor |
| 09/26/2001 | CN2450669Y Detecting box of quick paper slip method |
| 09/26/2001 | CN2450662Y Biological chip reading apparatus |
| 09/26/2001 | CN1315001A Method for rapid screening of analytes |
| 09/26/2001 | CN1315000A Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptide derived from said ssx gene and NY-ESO-1 gene, and uses thereof |
| 09/26/2001 | CN1314999A Modulating multiple lineage kinase proteins |
| 09/26/2001 | CN1314953A Method and compositions to identify swine genetically resistant to F18 E. coli associated diseases |
| 09/26/2001 | CN1314822A Disposable waste management device |
| 09/26/2001 | CN1314594A Method for labelling gene chip inverse transcription probe |
| 09/26/2001 | CN1314593A Test paper for detecting sterility and its test method |
| 09/26/2001 | CN1314592A Preparation of non-freezing shaped ice |
| 09/26/2001 | CN1314490A Method for producing yeast expressed human tissue plasminogen activator and its activity detection |
| 09/26/2001 | CN1314131A Eugenic test paper and its detection method |
| 09/25/2001 | US6295514 Method, system, and computer program product for representing similarity/dissimilarity between chemical compounds |
| 09/25/2001 | US6295506 Measurement apparatus |
| 09/25/2001 | US6294667 Separation of the fluorescently labelled carbohydrate substances, by virtue of their different charge-to-mass ratios or other factors, enabling a larger number of different labelled carbohydrate substances to be separated |